Stock Research for SGYP

SGYP

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

SGYP Stock Chart & Research Data

The SGYP chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SGYP chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


SGYP Due diligence Resources & Stock Charts

The SGYP stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View SGYP Detailed Price Forecast - CNN Money CNN View SGYP Detailed Summary - Google Finance
Yahoo View SGYP Detailed Summary - Yahoo! Finance Zacks View SGYP Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View SGYP Trends & Analysis - Trade-Ideas Barrons View SGYP Major Holders - Barrons
NASDAQ View SGYP Call Transcripts - NASDAQ Seeking View SGYP Breaking News & Analysis - Seeking Alpha
Spotlight View SGYP Annual Report - CompanySpotlight.com OTC Report View SGYP OTC Short Report - OTCShortReport.com
TradeKing View SGYP Fundamentals - TradeKing Charts View SGYP SEC Filings - Bar Chart
WSJ View Historical Prices for SGYP - The WSJ Morningstar View Performance/Total Return for SGYP - Morningstar
MarketWatch View the Analyst Estimates for SGYP - MarketWatch CNBC View the Earnings History for SGYP - CNBC
StockMarketWatch View the SGYP Earnings - StockMarketWatch MacroAxis View SGYP Buy or Sell Recommendations - MacroAxis
Bullish View the SGYP Bullish Patterns - American Bulls Short Pains View SGYP Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View SGYP Stock Mentions - StockTwits PennyStocks View SGYP Stock Mentions - PennyStockTweets
Twitter View SGYP Stock Mentions - Twitter Invest Hub View SGYP Investment Forum News - Investor Hub
Yahoo View SGYP Stock Mentions - Yahoo! Message Board Seeking Alpha View SGYP Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for SGYP - SECform4.com Insider Cow View Insider Transactions for SGYP - Insider Cow
CNBC View SGYP Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for SGYP - OTC Markets
Yahoo View Insider Transactions for SGYP - Yahoo! Finance NASDAQ View Institutional Holdings for SGYP - NASDAQ


Stock Charts

FinViz View SGYP Stock Insight & Charts - FinViz.com StockCharts View SGYP Investment Charts - StockCharts.com
BarChart View SGYP Stock Overview & Charts - BarChart Trading View View SGYP User Generated Charts - Trading View




Latest Financial News for SGYP


Synergy Pharmaceuticals Presents New Analyses Supporting the Use of TRULANCE® (plecanatide) in Two Patient Populations at the American College of Gastroenterology (ACG) Annual Scientific Meeting
Posted on Monday October 08, 2018

Synergy Pharmaceuticals Inc. (SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today announced that the company will present new analyses that further reinforce the efficacy and safety of TRULANCE® (plecanatide) for adult patients with chronic idiopathic constipation (CIC) or irritable bowel syndrome with constipation (IBS-C), specifically in patients aged 65 and older and in patients using concomitant acid suppression medications such as proton pump inhibitors (PPIs) and/or histamine receptor antagonists (H2 blockers).


Is the Options Market Predicting a Spike in Synergy Pharmaceuticals (SGYP) Stock?
Posted on Wednesday October 03, 2018

Investors need to pay close attention to Synergy Pharmaceuticals (SGYP) stock based on the movements in the options market lately.


Synergy Pharmaceuticals to Present New Analyses of TRULANCE® (Plecanatide) at the American College of Gastroenterology (ACG) Annual Scientific Meeting
Posted on Monday October 01, 2018

Synergy Pharmaceuticals Inc. (SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today announced that two posters will be presented at the American College of Gastroenterology (ACG) Annual Scientific Meeting, October 5-10, 2018, in Philadelphia, PA. Presentations include a poster detailing outcomes from a large post-hoc analysis evaluating the safety and tolerability of TRULANCE® (plecanatide) in chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C) in patients aged 65 and older compared to those in a younger cohort (≥18 to <65).


Synergy Pharmaceuticals Strengthens Coverage for TRULANCE® (plecanatide) with Key New Market Access Wins
Posted on Monday September 24, 2018

Synergy Pharmaceuticals Inc. (SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today announced several new formulary wins improving TRULANCE 2018 and 2019 coverage status across major U.S. Commercial, Medicare Part D and Managed Medicaid plans. “We are excited to announce several new formulary wins for TRULANCE, which we believe demonstrate our ongoing efforts to improve patient access and support future sales growth,” said Troy Hamilton, Chief Executive Officer of Synergy Pharmaceuticals Inc. “We believe the progress we’ve made towards strengthening market access is a result of our continued focus and commitment to optimizing the value of TRULANCE.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.